Vnitr Lek 2006, 52(11):1012-1013

Klinické důsledky TRIM (Transfusion related immunomodulation) - editorial

M. Průcha
Oddělení klinické biochemie, hematologie a imunologie Nemocnice Na Homolce, Praha, přednosta MUDr. Miroslav Průcha, Ph.D.

Received: June 26, 2006; Published: November 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Průcha M. Klinické důsledky TRIM (Transfusion related immunomodulation) - editorial. Vnitr Lek. 2006;52(11):1012-1013.
Download citation

References

  1. Marik PE, Sibbald WJ Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024-3029. Go to original source... Go to PubMed...
  2. Ho J, Milkovic S, Gray L et al. Transfusion of stored red blood cells occlude the rat microvasculature in vivo. Blood 2001; 98: 544a.
  3. Fransen E, Maessen J, Dentener M et al. Impact of blood transfusion on inflammatory mediators release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-1239. Go to original source... Go to PubMed...
  4. Prins HA, Houdijk AP, Nijveldt RJ et al. Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock 2001; 16: 113-115. Go to original source... Go to PubMed...
  5. Vamvakas E. Transfusion-associated cancer recurrence and infection: meta analysis of the randomized controlled clinical trials. Transfusion 1996; 36: 175-186. Go to original source... Go to PubMed...
  6. Mc Alister FA, Clard HD, Wells PS et al. Perioperative allogenic blood transfusion does not cause adverse sequelae in patients with cancer: a meta analysis of unconfounded studies. Br J Surg 1998; 85: 171-178. Go to original source... Go to PubMed...
  7. Corwin HL, Gettinger A, Pearl RG et al. The CRIT Study: anemia and blood transfusion in the critically ill; current clinical practice in the United States. Crit Care Med 2004; 32: 39-52. Go to original source... Go to PubMed...
  8. Vincent JL, Baron JF, Reinhart K et al. Anemia and blood transusion in critically ill patients. JAMA 2002; 288: 1499-1507. Go to original source... Go to PubMed...
  9. Townsend S, Dellinger RP, Levy MM, Ramsay G (eds). 2005 by the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, and the International Sepsis Forum. Implementing The Surviving Sepsis Campaign.
  10. Corwin HL, AuBcho JP Is leukoreduction of blood components for everyone? JAMA 2003; 289: 1993-1995. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.